SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001654954-17-008691
Filing Date
2017-09-21
Accepted
2017-09-21 17:28:07
Documents
1
Period of Report
2017-09-19

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT section16.html 4  
1 PRIMARY DOCUMENT section16.xml 4 5616
  Complete submission text file 0001654954-17-008691.txt   7263
Mailing Address 222 THIRD STREET SUITE #2240 CAMBRIDGE MA 02142
Business Address 222 THIRD STREET SUITE #2240 CAMBRIDGE MA 02142 (844) 902-6100
Acer Therapeutics Inc. (Issuer) CIK: 0001069308 (see all company filings)

IRS No.: 760333165 | State of Incorp.: TX | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 6300 DUMBARTON CIRCLE FREMONT CA 94555
Business Address
ASELAGE STEVE (Reporting) CIK: 0001221599 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33004 | Film No.: 171096398